Category: Drug Discovery
Drug Discovery market research reports by GlobalData
-
Hypertriglyceridemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Hypertriglyceridemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Hypertriglyceridemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, ... Read More
-
Osteoarthritis Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021 - 2031
Osteoarthritis Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021 - 2031 Summary Osteoarthritis (OA) is the most common joint disease and a major cause of disability and pain among the elderly in ... Read More
-
Leishmaniasis (Kala-Azar) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Leishmaniasis (Kala-Azar) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Leishmaniasis (Kala-Azar) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, En ... Read More
-
Schizophrenia Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
Schizophrenia Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 Summary Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The diso ... Read More
-
HER2- Breast Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
HER2- Breast Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in HER2- Breast Cancer therapeutics. Synopsis In 2022, there will be more than one million incide ... Read More
-
Hospital Acquired Pneumonia Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Hospital Acquired Pneumonia Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Hospital Acquired Pneumonia therapeutics. Synopsis In 2022, there will be more than 30 ... Read More
-
Urticaria Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Urticaria Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Urticaria therapeutics. Synopsis In 2022, there will be more than 80 million diagnosed prevalent cases o ... Read More
-
Methicillin-Resistant Staphylococcus Aureus (MRSA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Methicillin-Resistant Staphylococcus Aureus (MRSA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in MRSA therapeutics. Synopsis In 2022, there will be more than 85 ... Read More
-
Fungal Infections Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Fungal Infections Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Fungal Infections therapeutics. Synopsis In 2022, there will be more than three million incident ... Read More
-
Age-Related Macular Degeneration Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
Age-Related Macular Degeneration Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 Summary Macular degeneration is the breakdown of the macula, a small, oval-shaped area of the retina that ... Read More
-
Pharmaceutical Drug Development Sector Scorecard, Q2 2022 Update - Thematic Research
Pharmaceutical Drug Development Sector Scorecard, Q2 2022 Update - Thematic Research Summary The Genomics Landscape Continues to Be Dynamic in Q2 2022 With Less Activity Seen in Immuno-oncology. The genomics landscape was active in Q2 2022, with scores increased for several companies. This includes ... Read More
-
Artificial Intelligence (AI) in Drug Discovery - Thematic Research
Artificial Intelligence (AI) in Drug Discovery - Thematic Research Summary In recent years, driven by the COVID-19 pandemic, the pharma industry has undergone increased levels of digital transformation. The availability of ultra-large datasets and technological advances has led to more interest in t ... Read More
-
Interstitial Cystitis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Interstitial Cystitis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Interstitial Cystitis therapeutics. Key Highlights In 2022, there will be more than one mill ... Read More
-
Polymyositis and Dermatomyositis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Polymyositis and Dermatomyositis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Polymyositis and Dermatomyositis therapeutics. In 2022, there will be more than 3 ... Read More
-
Focal Segmental Glomerulosclerosis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Focal Segmental Glomerulosclerosis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Focal Segmental Glomerulosclerosis therapeutics. Key Highlights In 2022, there ... Read More
-
Nontuberculous Mycobacteria (NTM) Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
Nontuberculous Mycobacteria (NTM) Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 Summary Diagnosed prevalent cases of Nontuberculous Mycobacteria (NTM) infections are expected to increas ... Read More
-
Major Depressive Disorder Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Major Depressive Disorder Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Major Depressive Disorder therapeutics. Synopsis In 2022, there will be more than 18 mil ... Read More
-
Rosacea Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Rosacea Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Rosacea therapeutics. Synopsis In 2022, there will be more than 47 million diagnosed prevalent cases of ro ... Read More
-
Aicardi-Goutieres Syndrome Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Aicardi-Goutieres Syndrome Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Aicardi-Goutieres Syndrome therapeutics. Synopsis There will be more than 4,000 prevale ... Read More
-
Microbiome-Targeting Therapeutics in Infectious Diseases - Thematic Research
Microbiome-Targeting Therapeutics in Infectious Diseases - Thematic Research Summary Microbiome-targeting drugs aim to alter the microbial composition of the gut through the administration of live microbes with the intention of regulating the human microbiome composition in a beneficial way that may ... Read More
-
Clinical Trials - Where are we Headed with COVID-19 Trials?
Clinical Trials - Where are we Headed with COVID-19 Trials? Summary This report provides an overview of global COVID-19 clinical trials extracted from the GlobalData Pharma Intelligence Center on March 30, 2022. The purpose of this report is to provide insight into the overall clinical trial landsca ... Read More
-
Smoking Cessation Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape
Smoking Cessation Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Smoking Cessation therapeutics. Synopsis In 2022, Nearly 350 million people will q ... Read More
-
Cartilage Repair Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Cartilage Repair Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update Summary GlobalData's Medical Devices sector report, “Cartilage Repair Pipeline Report including Stages of Development, Segments, Region and Countries, Regu ... Read More
-
Hydrocephalus Shunts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Hydrocephalus Shunts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update Summary GlobalData's Medical Devices sector report, “Hydrocephalus shunts Pipeline Report including Stages of Development, Segments, Region and Countri ... Read More
-
Neuroimmunology Drug Development - Thematic Research
Neuroimmunology Drug Development - Thematic Research Summary This report provides an overview of neuroimmunology drug development within eight key indications across eight pharmaceutical markets. The neuroimmune system is complex and a critical component in regulating nervous system health and disea ... Read More
Research Assistance
